Sapiens Q2 revenue up 3.5%, beats expectations

Reuters
2025/08/13
Sapiens <a href="https://laohu8.com/S/QTWO">Q2</a> revenue up 3.5%, beats expectations

Overview

  • Sapiens Q2 2025 rev rises 3.5% yr/yr, beating analysts' expectations

  • Adjusted EPS and net income for Q2 beat consensus

  • Co completed acquisitions of Advantage Go and Candella, boosting P&C and Life segments

Outlook

  • Sapiens expects acquisitions to strengthen P&C and Life growth

  • Company aims to accelerate cloud adoption and expand globally

  • Sapiens focuses on platform innovation and cross-selling for growth

  • Company sees growth catalysts in Life & Annuities expansion

Result Drivers

  • STRATEGIC PRIORITIES - Co executed strategic priorities by securing new deals and strengthening customer relationships in Life, P&C, and Reinsurance segments, per CEO Roni Al-Dor

  • ACQUISITIONS - Completed acquisitions of Advantage Go and Candella to strengthen P&C and Life growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$141.60 mln

$140 mln (4 Analysts)

Q2 Adjusted EPS

Beat

$0.34

$0.32 (4 Analysts)

Q2 EPS

$0.25

Q2 Adjusted Net Income

Beat

$19.30 mln

$18.10 mln (4 Analysts)

Q2 Adjusted Operating Income

Beat

$23.10 mln

$21.60 mln (4 Analysts)

Q2 Adjusted Gross Margin

45.8%

Q2 Adjusted Gross Profit

$64.80 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy."

  • Wall Street's median 12-month price target for Sapiens International Corporation NV is $31.00, about 4.8% above its August 12 closing price of $29.50

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nPn89NWJca

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10